Guardian Pharmacy Services GRDN
$46.94 +$0.27 (+0.58%)
Market closed · Nov 22, 6:40 am ET · Last extended-hours $46.94 0.00%
Open$46.40
Prev close$46.67
Day range$46.13 – $47.48
Volume526.7K
Market cap$2.97B
P/E (TTM)40.1
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$371.07M-1.7% YoY
Operating profit$25.06M+53.3% YoY
Net profit$19.12M+99.3% YoY
Diluted EPS$0.29+93.3% YoY
Free cash flow$39.34M+71.3% YoY
Operating cash flow$43.37M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin22.4%
Operating margin6.5%
Net margin5.1%
Return on equity33.2%
Return on assets17.0%
Return on invested capital28.9%
Current ratio1.65
Liabilities / assets43.1%
Cash & investments$119.66M
Total debt$27.96M
Net cash (debt)$91.69M
Free cash flow / sales6.6%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $371.07M | $351.77M | $336.60M | $1.45B | $397.62M |
| Total Operating Revenue | $371.07M | $351.77M | $336.60M | $1.45B | $397.62M |
| Cost of Revenue | $285.85M | $271.72M | $260.29M | $1.16B | $312.11M |
| Gross Profit | $85.22M | $80.04M | $76.31M | $292.72M | $85.50M |
| Operating Expense | $60.16M | $59.40M | $58.63M | $220.02M | $54.74M |
| Selling and Admin Expenses | $60.16M | $59.40M | $58.63M | $220.02M | $54.74M |
| Operating Profit | $25.06M | $20.64M | $17.68M | $72.70M | $30.76M |
| Net Non-Operating Interest Income (Expense) | -$177,000.00 | -$154,000.00 | -$154,000.00 | -$665,000.00 | -$163,000.00 |
| Non-Operating Interest Expense | $177,000.00 | $154,000.00 | $154,000.00 | $665,000.00 | $163,000.00 |
| Other Income (Expense) | $1.09M | $9.30M | $772,000.00 | $1.39M | $500,000.00 |
| Other Non-Operating Income (Expenses) | $1.09M | $9.30M | $772,000.00 | $1.39M | $500,000.00 |
| Pretax Profit | $25.98M | $29.79M | $18.29M | $73.42M | $31.10M |
| Tax | $6.86M | $7.67M | $4.75M | $24.47M | $9.83M |
| Net Profit | $19.12M | $22.12M | $13.54M | $48.96M | $21.27M |
| Profit from Continuing Operations | $19.12M | $22.12M | $13.54M | $48.96M | $21.27M |
| Minority Interests | $440,000.00 | $249,000.00 | $249,000.00 | -$261,000.00 | $342,000.00 |
| Net Income to Parent Company | $18.68M | $21.87M | $13.30M | $49.22M | $20.92M |
| Net Income to Common Stockholders | $18.68M | $21.87M | $13.30M | $49.22M | $20.92M |
| Basic EPS | $0.29 | $0.35 | $0.21 | $0.79 | $0.33 |
| Diluted EPS | $0.29 | $0.34 | $0.21 | $0.78 | $0.33 |
| Other Preferred Stock Dividends | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $491.78M | $443.58M | $426.94M | $412.66M | $412.66M |
| Total Current Assets | $294.82M | $254.67M | $235.18M | $221.63M | $221.63M |
| Cash and Cash Equivalents & Short-Term Investments | $119.66M | $89.81M | $64.89M | $65.62M | $65.62M |
| -Cash and Cash Equivalents | $119.66M | $89.81M | $64.89M | $65.62M | $65.62M |
| Receivables | $107.68M | $103.77M | $111.70M | $101.61M | $101.61M |
| -Accounts Receivable | $107.68M | $103.77M | $111.70M | $101.61M | $101.61M |
| Inventory | $57.05M | $50.44M | $47.16M | $43.36M | $43.36M |
| Other Current Assets | $10.43M | $10.65M | $11.43M | $11.04M | $11.04M |
| Total Non-Current Assets | $196.96M | $188.91M | $191.76M | $191.02M | $191.02M |
| Net PPE | $90.20M | $88.89M | $90.89M | $90.17M | $90.17M |
| -Gross PPE | $90.20M | $88.89M | $90.89M | $178.02M | $178.02M |
| Goodwill and Other Intangible Assets | $102.80M | $96.36M | $97.23M | $98.22M | $98.22M |
| -Goodwill | $81.95M | $79.74M | $79.74M | $79.74M | $79.74M |
| -Other Intangible Assets | $20.84M | $16.62M | $17.48M | $18.48M | $18.48M |
| Non-Current Deferred Assets | $2.62M | $2.20M | $2.20M | $2.20M | $2.20M |
| Other Non-Current Assets | $1.35M | $1.46M | $1.45M | $436,000.00 | $436,000.00 |
| Total Liabilities | $212.06M | $185.94M | $194.52M | $194.73M | $194.73M |
| Total Current Liabilities | $179.09M | $154.04M | $160.54M | $160.70M | $160.70M |
| Payables | $126.31M | $108.21M | $108.55M | $116.21M | $116.21M |
| -Accounts Payable | $126.31M | $108.21M | $108.55M | $116.21M | $116.21M |
| Short-Term Debt and Capital Lease Obligation | $7.63M | $7.38M | $7.22M | $7.15M | $7.15M |
| -Current Capital Lease Obligation | $7.63M | $7.38M | $7.22M | $7.15M | $7.15M |
| Other Current Liabilities | $25.28M | $23.37M | $31.98M | $22.30M | $22.30M |
| Total Non-Current Liabilities | $32.97M | $31.89M | $33.97M | $34.03M | $34.03M |
| Long Term Debt and Capital Lease Obligation | $27.96M | $27.86M | $29.67M | $29.99M | $29.99M |
| -Long Term Capital Lease Obligation | $27.96M | $27.86M | $29.67M | $29.99M | $29.99M |
| Other Non-Current Liabilities | $5.01M | $4.03M | $4.31M | $4.04M | $4.04M |
| Total Equity | $279.72M | $257.64M | $232.42M | $217.92M | $217.92M |
| Stockholders' Equity | $267.24M | $245.61M | $220.89M | $205.76M | $205.76M |
| Capital Stock | $63,000.00 | $63,000.00 | $63,000.00 | $63,000.00 | $63,000.00 |
| -Common Stock | $63,000.00 | $63,000.00 | $63,000.00 | $63,000.00 | $63,000.00 |
| Additional Paid-In Capital | $146.98M | $144.04M | $141.19M | $139.35M | $139.35M |
| Retained Earnings | $120.19M | $101.51M | $79.64M | $66.34M | $66.34M |
| Minority Interests | $12.49M | $12.03M | $11.53M | $12.17M | $12.17M |
| -Accumulated Depreciation | – | – | – | -$87.85M | -$87.85M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $43.37M | $30.03M | $6.06M | $100.26M | $34.60M |
| Net cash flow from continuing operations | $43.37M | $30.03M | $6.06M | $100.26M | $34.60M |
| Net Income from Continuing Operations | $19.12M | $22.12M | $13.54M | $48.96M | $21.27M |
| Depreciation & Depletion & Amortization | $5.93M | $5.81M | $5.98M | $22.34M | $5.74M |
| Other Non-Cash Items | -$161,000.00 | $118,000.00 | -$79,000.00 | $1.08M | $490,000.00 |
| Change in Working Capital | $14.89M | -$2.74M | -$16.30M | $6.38M | $2.19M |
| -Change in Receivables | -$4.89M | $6.25M | -$11.13M | -$8.55M | $3.04M |
| -Change in Inventory | -$6.00M | -$3.28M | -$3.80M | -$877,000.00 | $4.79M |
| -Change in Payables and Accrued Expense | $22.38M | $2.05M | -$10.06M | $17.02M | -$5.65M |
| -Change in Other Current Assets | $409,000.00 | $766,000.00 | -$1.39M | -$2.48M | -$3.34M |
| -Change in Other Current Liabilities | $2.99M | -$8.52M | $10.08M | $1.28M | $3.34M |
| Net cash flow from investing | -$10.90M | -$4.31M | -$4.75M | -$32.23M | -$4.71M |
| Net Cash Flow from Continuing Investing Activities | -$10.90M | -$4.31M | -$4.75M | -$32.23M | -$4.71M |
| Net PPE Purchase and Sale | -$4.03M | -$4.89M | -$4.75M | -$19.55M | -$4.23M |
| Net Business Purchase and Sale | -$2.64M | – | – | -$13.42M | -$495,000.00 |
| Net Other Investing Changes | -$4.24M | – | – | $736,000.00 | $12,000.00 |
| Financing Cash Flow | -$2.62M | -$805,000.00 | -$2.04M | -$7.07M | -$758,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$2.62M | -$805,000.00 | -$2.04M | -$7.07M | -$758,000.00 |
| Net Issuance Payments Of Debt | -$1.06M | -$1.04M | -$1.12M | -$4.98M | -$1.09M |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Other Financing Charges | -$1.56M | $234,000.00 | -$921,000.00 | -$2.09M | $332,000.00 |
| Ending Cash Balance | $119.66M | $89.81M | $64.89M | $65.62M | $65.62M |
| Net Change in Cash | $29.85M | $24.91M | -$726,000.00 | $60.96M | $29.13M |
| Beginning Cash Balance | $89.81M | $64.89M | $65.62M | $4.66M | $36.49M |
| Free Cash Flow | $39.34M | $25.41M | $1.04M | $80.71M | $30.37M |
| Deferred Tax | – | – | – | $3.07M | $2.36M |
| Cash Dividends Paid | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on GRDN.
Sign in to join the discussion.